Skip to content
envelope-open icon


News - Atlantia Clinical Trials

Atlantia Clinical Trials Expands to the US

The clinical unit site launch

Washington D.C., March 13th, 2019. At an event in Washington DC, An Taoiseach, Leo Varadkar TD, today announced the opening of new offices for Cork-based Atlantia Clinical Trials in Chicago.  Atlantia Food Clinical Trials will create an initial six jobs on opening in Chicago, growing to 20 positions within two years.

Speaking at the announcement, An Taoiseach, Leo Varadkar TD, said:

The opening of Atlantia Clinical Trials in Chicago is fantastic news for the company and for Ireland.  It marks the next significant phase of the company’s development and shows Atlantia’s commitment to delivering a broad spectrum of clinical studies, which ultimately contribute to healthier lifestyles. It is testament to the innovative entrepreneurs that we have in Ireland who are building on our research capabilities and responding to market demand globally.

Atlantia Clinical Trials is a highly specialised, Enterprise Ireland-supported company, and a spin out of the APC Microbiome Ireland SFI Research Centre, which is funded by Science Foundation Ireland and hosted at University College Cork.

The company is a Contract Research Organisation (CRO) that specialises in conducting studies in foods, supplements and live biotherapeutics for companies world-wide that want to scientifically validate their functional ingredients to support an EFSA (European Food Safety Authority) Health Claim, FDA (Food & Drug Administration) Structure Function Claim, or General Product Marketing Claim.

Speaking about the company's growth and success, Andrea Doolan, Chief Executive Officer and Co-founder at Atlantia Clinical Trials, said:

The decision to expand our clinic base in Chicago is due to the ever-increasing demand for clinical trials on functional foods. This industry is in a phase of rapid discovery and strong growth, and as a leading expert in clinical studies, we can help our clients to deliver on their product development needs, in a highly competitive market.

Welcoming the announcement, Julie Sinnamon, CEO of Enterprise Ireland, said:

We are delighted to continue our support of Atlantia Clinical Trials into the next phase of their development, having supported the company to initially explore the US market through the Enterprise Ireland Discovery Fund. The company is providing a unique service, carried out by inhouse experts who have grown from a foundation of research excellence at UCC. This US expansion demonstrates an impressive commitment to the functional ingredients market, which is now worth in excess of €45billion.

Prof Mark Ferguson, Director General at Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland said:

World-leading SFI Research Centres are recognised internationally. As well as attracting talent and capital to Ireland, they foster cutting-edge spin out companies and continue to successfully deliver on their mandate for excellent research with strong economic and societal impact. I am delighted to congratulate Atlantia Food Clinical Trials, on its expansion in Chicago and wish them every continued success.

Atlantia Clinical Trials is uniquely positioned in the marketplace, running and operating its own clinic sites. Its team includes physician experts in digestive health, mental health, cardiovascular health, sports performance, metabolic disease, bone health, immune health and healthy ageing. The clinical team includes project managers, research nurses, nutritionists, certified sports trainers and lab researchers.

Atlantia Clinical Trials continues to collaborate with the APC Microbiome Ireland SFI Research Centre, Teagasc and other recognised centres of excellence globally.

The clinical trial site expansion

Chicago IL, October 27, 2020. After months of delays due to the unprecedented arrival of Covid-19, Atlantia proudly announces the opening of new Chicago based clinical research site.

The new 7000sq ft site in 142. E. Ontario Suite 1200, Downtown Chicago is a testament to the hard work and dedication of the Atlantia team. Speaking on the move from a smaller clinical site in Chicago, Andrea Doolan, Chief Executive Officer and Co-founder at Atlantia Clinical Trials, stated:

Atlantia Clinical Trials has already grown too big for the Chicago office it opened almost two years ago. The demand for our services has exceeded expectations and we simply need much more room to accommodate our operations.

This demand for substantiated data is driven by consumer trends. Similarly, business to business sellers require validated data prior to purchasing ingredients they intend on using for their product.

The company has conducted over 120 studies and is an industry leader in delivering human clinical studies across a multitude of health areas. This is a result of the ability to meet the needs and expectations of sponsor companies, while also operating under the research based foundation of the company to conduct clinical trials at the highest standard. Atlantia Clinical Trials began life as a spinout of APC Microbiome Ireland, a world renowned SFI Research Centre, providing an immediate competitive advantage as the foundation of the company is based on quality research, and connects the company to the highly published academic community. As a result of such passion for quality, Atlantia are one of few companies globally that offer ICH-GCHP standards in human clinical trials.

Atlantia is uniquely positioned in the marketplace, running and operating its own clinical sites on a multinational level. Barry Skillington, Chief Commercial Officer and Co-founder at Atlantia Clinical Trials, outlines:

We can offer multicentre and multinational trials within our own organisation, which reduces the noise in the dataset.

This is particularly relevant for companies aiming to bring their product to a global market, in order to launch globally they may consider European clinical data as well as US data, and Atlantia possess the ability to recruit populations in both markets.

New facility features:

  • 15 Clinic rooms
  • Central phlebotomy lab
  • Locked -80° Celsius storage
  • Locked refrigerated/ambient storage
  • Sample preparation lab

What lies ahead for Atlantia Clinical Trials in Chicago? We will continue to keep providing excellent multinational clinical trial services to companies aiming to validate the health benefits of their food, probiotics, live therapeutics and medical food products through human clinical trials.

Atlantia delivers ICH-GCP standard clinical studies for functional ingredients in foods & beverages, medical foods, dietary supplements, probiotics, prebiotics and microbiome-based therapeutics on digestive health as well as many other health areas, Visit our clinical expertise areas. The team at Atlantia includes physician experts in digestive health, mental health, cardiovascular health, sports performance, metabolic disease, bone health, immune health and healthy ageing.

Admin / About Author